Therapeutics

EyeCare Partners Announces Strategic Debt Restructuring Moves

April 23, 2024

Sean A. MacDonald Appointed CEO of Domain Therapeutics

April 22, 2024

Bicara Therapeutics Bolsters Clinical Team

March 28, 2024

Avenzo Therapeutics Closes $150M Series A-1 Financing

March 28, 2024

Capstan Therapeutics Secures $175M in Series B

March 25, 2024

Siolta Therapeutics Secures $12M for Microbiome Innovation

March 20, 2024

Kenai Therapeutics Secures $82M in Series A Funding

March 6, 2024

BlossomHill Therapeutics Secures $100M Series B

March 6, 2024

Domain Therapeutics Appoints New CSO to Lead Research

March 5, 2024

Rapport Therapeutics Welcomes New CPO

March 4, 2024